Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction
Ming Zhao, Ji Li, Jingwen Liu, et al.
Journal of Controlled Release (2021) Vol. 335, pp. 320-332
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Nano Delivery of Chemotherapeutic ICD Inducers for Tumor Immunotherapy
Jianfeng Guo, Yifang Zou, Leaf Huang
Small Methods (2023) Vol. 7, Iss. 5
Closed Access | Times Cited: 53
Exploring nanocarriers as innovative materials for advanced drug delivery strategies in onco-immunotherapies
Pratiksha Tiwari, Ravi Prakash Shukla, Krishna Yadav, et al.
Journal of Molecular Graphics and Modelling (2024) Vol. 128, pp. 108702-108702
Closed Access | Times Cited: 19
Cardiovascular disease: Mitochondrial dynamics and mitophagy crosstalk mechanisms with novel programmed cell death and macrophage polarisation
Dandan Liu, Hewei Qin, Yang Gao, et al.
Pharmacological Research (2024) Vol. 206, pp. 107258-107258
Open Access | Times Cited: 18
Hollow copper sulfide nanoparticles carrying ISRIB for the sensitized photothermal therapy of breast cancer and brain metastases through inhibiting stress granule formation and reprogramming tumor‐associated macrophages
Fan Tong, Haili Hu, Yanyan Xu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 8, pp. 3471-3488
Open Access | Times Cited: 48
Engineering nanoparticles boost TNBC therapy by CD24 blockade and mitochondrial dynamics regulation
Ming Zhao, Ji Li, Fan Chen, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 211-227
Closed Access | Times Cited: 27
Unraveling the potential of 3D bioprinted immunomodulatory materials for regulating macrophage polarization: State-of-the-art in bone and associated tissue regeneration
Sayan Deb Dutta, Tejal V. Patil, Keya Ganguly, et al.
Bioactive Materials (2023) Vol. 28, pp. 284-310
Open Access | Times Cited: 27
Stimuli‐Responsive Nanotechnology for RNA Delivery
Hui Zhou, Dean Shuailin Chen, Caleb J. Hu, et al.
Advanced Science (2023) Vol. 10, Iss. 36
Open Access | Times Cited: 25
Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 12
Engineering nanomedicines for immunogenic eradication of cancer cells: Recent trends and synergistic approaches
Ahmed O. Elzoghby, Omar Samir, Hagar E. S. Emam, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2475-2504
Open Access | Times Cited: 10
Platinum(IV)-Backboned Polymer Prodrug-Functionalized Manganese Oxide Nanoparticles for Enhanced Lung Cancer Chemoimmunotherapy via Amplifying Stimulator of Interferon Genes Activation
Li Liu, Shengxiang Fu, Haojie Gu, et al.
ACS Nano (2025)
Closed Access | Times Cited: 1
Lenalidomide-utilizing self-assembled immunogenic cell death-inducing heparin/doxorubicin nanocomplex for anticancer immunotherapy
Minho Seo, Yun‐Hwa Jeong, Bison Seo, et al.
Nano Today (2025) Vol. 62, pp. 102677-102677
Closed Access | Times Cited: 1
Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies
Yuanyuan Guo, Fengyuan Gao, Adeel Ahmed, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 36, pp. 8586-8604
Closed Access | Times Cited: 18
Immunomodulatory and immune-toxicological role of nanoparticles: Potential therapeutic applications
Somnath Sau, Alo Dey, Pritam Pal, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112251-112251
Closed Access | Times Cited: 7
Size-switchable and dual-targeting nanomedicine for cancer chemoimmunotherapy by potentiating deep tumor penetration and antitumor immunity
Lu Tang, Yue Yin, Ziyao Zhang, et al.
Chemical Engineering Journal (2024) Vol. 493, pp. 152590-152590
Closed Access | Times Cited: 7
Nanodelivery of scutellarin induces immunogenic cell death for treating hepatocellular carcinoma
Linlin Li, Yifang Zou, Lingzhi Wang, et al.
International Journal of Pharmaceutics (2023) Vol. 642, pp. 123114-123114
Closed Access | Times Cited: 14
Immunomodulation, Toxicity, and Therapeutic Potential of Nanoparticles
Ashutosh Pandey, Abhinava K. Mishra
BioTech (2022) Vol. 11, Iss. 3, pp. 42-42
Open Access | Times Cited: 20
When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy
Linna Yu, Yi Jin, Mingjie Song, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1589-1589
Open Access | Times Cited: 18
A combination of genetically engineered oncolytic virus and melittin-CpG for cancer viro-chemo-immunotherapy
Amirhossein Bahreyni, Huitao Liu, Yasir Mohamud, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Stimuli‐responsive nanodelivery systems for amplifying immunogenic cell death in cancer immunotherapy
Wenhao Xu, Wangrui Liu, Jianfeng Yang, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 181-198
Closed Access | Times Cited: 10
Non-cytotoxic nanoparticles re-educating macrophages achieving both innate and adaptive immune responses for tumor therapy
Shengmei Wang, Xuanjun Liu, Minghua Yang, et al.
Asian Journal of Pharmaceutical Sciences (2022) Vol. 17, Iss. 4, pp. 557-570
Open Access | Times Cited: 15
Promotion of ICD via Nanotechnology
Yang Qin, Haitao Zhang, Yunxian Li, et al.
Macromolecular Bioscience (2023) Vol. 23, Iss. 9
Closed Access | Times Cited: 8
Co-delivery systems of paclitaxel prodrug for targeted synergistic therapy of breast cancer
Yin Wang, Liu Tian, Shengchun Wang, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 69, pp. 103157-103157
Closed Access | Times Cited: 13
Advancements in nanomedicine delivery systems: unraveling immune regulation strategies for tumor immunotherapy
Yi Zhang, Xi Chen, Binbin Hu, et al.
Nanomedicine (2024), pp. 1-20
Closed Access | Times Cited: 2
Charge-Reversal Nano-Drug Delivery Systems in the Tumor Microenvironment: Mechanisms, Challenges, and Therapeutic Applications
Yizhu Liang, Jiashuai Wu, Yutong Yan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9779-9779
Open Access | Times Cited: 2
Orchestrating cancer therapy: Recent advances in nanoplatforms harmonize immunotherapy with multifaceted treatments
Rongwei Xu, Pei Lin, Jiarong Zheng, et al.
Materials Today Bio (2024) Vol. 30, pp. 101386-101386
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top